TY - JOUR
T1 - Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
AU - Nicolas, Aude
AU - Kenna, Kevin P.
AU - Renton, Alan E.
AU - Ticozzi, Nicola
AU - Faghri, Faraz
AU - Chia, Ruth
AU - Dominov, Janice A.
AU - Kenna, Brendan J.
AU - Nalls, Mike A.
AU - Keagle, Pamela
AU - Rivera, Alberto M.
AU - van Rheenen, Wouter
AU - Murphy, Natalie A.
AU - van Vugt, Joke J.F.A.
AU - Geiger, Joshua T.
AU - van der Spek, Rick
AU - Pliner, Hannah A.
AU - [Unknown], Shankaracharya
AU - Smith, Bradley N.
AU - Marangi, Giuseppe
AU - Topp, Simon D.
AU - Abramzon, Yevgeniya
AU - Gkazi, Athina Soragia
AU - Eicher, John D.
AU - Kenna, Aoife
AU - Logullo, Francesco O.
AU - Simone, Isabella
AU - Logroscino, Giancarlo
AU - Salvi, Fabrizio
AU - Bartolomei, Ilaria
AU - Borghero, Giuseppe
AU - Murru, Maria Rita
AU - Costantino, Emanuela
AU - Pani, Carla
AU - Puddu, Roberta
AU - Caredda, Carla
AU - Piras, Valeria
AU - Fratta, Pietro
AU - Fogh, Isabella
AU - Al-Sarraj, Safa
AU - Troakes, Claire
AU - Vance, Caroline
AU - Shatunov, Aleksey
AU - Al-Chalabi, Ammar
AU - Iacoangeli, Alfredo
AU - Newhouse, Stephen
AU - Shaw, Chris
AU - Sproviero, William
AU - Shaw, Christopher E.
AU - ITALSGEN Consortium
AU - Genomic Translation for ALS Care (GTAC) Consortium
AU - NYGC ALS Consortium
AU - Answer ALS Foundation
AU - Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium
AU - SLAGEN Consortium
AU - French ALS Consortium
AU - Project MinE ALS Sequencing Consortium
AU - Al Khleifat, Ahmad
PY - 2018/3/21
Y1 - 2018/3/21
N2 - To identify novel genes associated with ALS, we undertook two lines of investigation. We carried out a genome-wide association study comparing 20,806 ALS cases and 59,804 controls. Independently, we performed a rare variant burden analysis comparing 1,138 index familial ALS cases and 19,494 controls. Through both approaches, we identified kinesin family member 5A (KIF5A) as a novel gene associated with ALS. Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia (SPG10) and Charcot-Marie-Tooth type 2 (CMT2). In contrast, ALS-associated mutations are primarily located at the C-terminal cargo-binding tail domain and patients harboring loss-of-function mutations displayed an extended survival relative to typical ALS cases. Taken together, these results broaden the phenotype spectrum resulting from mutations in KIF5A and strengthen the role of cytoskeletal defects in the pathogenesis of ALS.
AB - To identify novel genes associated with ALS, we undertook two lines of investigation. We carried out a genome-wide association study comparing 20,806 ALS cases and 59,804 controls. Independently, we performed a rare variant burden analysis comparing 1,138 index familial ALS cases and 19,494 controls. Through both approaches, we identified kinesin family member 5A (KIF5A) as a novel gene associated with ALS. Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia (SPG10) and Charcot-Marie-Tooth type 2 (CMT2). In contrast, ALS-associated mutations are primarily located at the C-terminal cargo-binding tail domain and patients harboring loss-of-function mutations displayed an extended survival relative to typical ALS cases. Taken together, these results broaden the phenotype spectrum resulting from mutations in KIF5A and strengthen the role of cytoskeletal defects in the pathogenesis of ALS.
KW - ALS
KW - KIF5A
KW - GWAS
KW - WES
KW - WGS
KW - cargo
KW - axonal transport
U2 - 10.1016/j.neuron.2018.02.027
DO - 10.1016/j.neuron.2018.02.027
M3 - Article
SN - 0896-6273
VL - 97
SP - 1268
JO - Neuron
JF - Neuron
IS - 6
ER -